We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+10.7%
1 Year Est. Return
+31.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$286M
AUM Growth
-$122M
Cap. Flow
-$144M
Cap. Flow %
-50.52%
Top 10 Hldgs %
24.12%
Holding
143
New
41
Increased
10
Reduced
49
Closed
34

Top Buys

Rank Stock Value
1
OMC icon
Omnicom Group
OMC
+$8.21M
2
SCI icon
Service Corp International
SCI
+$7.9M
3
CLLS
Cellectis
CLLS
+$6.83M
4
SF
Stifel
SF
+$6.38M
5
AAP icon
Advance Auto Parts
AAP
+$6.34M

Top Sells

Rank Stock Value
1
NTLA icon
Intellia Therapeutics
NTLA
+$14.5M
2
TWST icon
Twist Bioscience
TWST
+$10.6M
3
NVTA
Invitae Corporation
NVTA
+$9.84M
4
VCYT icon
Veracyte
VCYT
+$8.46M
5
EXAS
Exact Sciences
EXAS
+$8.24M

Sector Composition

Rank Sector Weight
1 Healthcare 25.23%
2 Technology 20.11%
3 Consumer Discretionary 16.12%
4 Financials 12.25%
5 Communication Services 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PNFP icon
26
Pinnacle Financial Partners Inc
PNFP
$15.8B
$3.85M 1.35%
43,363
+15,369
+55% +$1.22M
CTAS icon
27
Cintas
CTAS
$86.6B
$3.75M 1.31%
+43,960
New +$3.72M
TRUP icon
28
Trupanion
TRUP
$1.13B
$3.73M 1.31%
49,000
– –
EPAM icon
29
EPAM Systems
EPAM
$5.58B
$3.73M 1.31%
9,398
+3,308
+54% +$1.21M
ENOV icon
30
Enovis
ENOV
$1.74B
$3.58M 1.25%
+47,478
New +$3.48M
TTEC icon
31
TTEC Holdings
TTEC
$124M
$3.55M 1.24%
+35,328
New +$3M
NVDA icon
32
NVIDIA
NVDA
$4.6T
$3.49M 1.22%
261,680
-89,640
-26% -$1.2M
ZYXI
33
DELISTED
Zynex
ZYXI
$3.46M 1.21%
249,615
-53,472
-18% -$816K
TWST icon
34
Twist Bioscience
TWST
$5.32B
$3.33M 1.17%
26,892
-70,108
-72% -$10.6M
VEEV icon
35
Veeva Systems
VEEV
$33.8B
$3.3M 1.15%
12,622
+837
+7% +$233K
META icon
36
Meta Platforms (Facebook)
META
$1.49T
$3.27M 1.15%
11,107
-893
-7% -$240K
LMAT icon
37
LeMaitre Vascular
LMAT
$2.37B
$3.18M 1.11%
65,173
– –
BLK icon
38
Blackrock
BLK
$167B
$3.08M 1.08%
4,090
-1,350
-25% -$979K
DLTR icon
39
Dollar Tree
DLTR
$24.8B
$3.03M 1.06%
+26,499
New +$2.85M
EVR icon
40
Evercore
EVR
$11.8B
$3.03M 1.06%
+23,000
New +$2.81M
HCI icon
41
HCI Group
HCI
$2.34B
$3.01M 1.05%
+39,221
New +$2.47M
UTHR icon
42
United Therapeutics
UTHR
$26.1B
$2.95M 1.03%
17,638
-1,394
-7% -$232K
MEDP icon
43
Medpace
MEDP
$16.3B
$2.9M 1.02%
17,698
– –
NIU
44
Niu Technologies
NIU
$200M
$2.82M 0.99%
77,048
-71,752
-48% -$2.9M
MASI
45
DELISTED
Masimo
MASI
$2.72M 0.95%
11,850
-11,000
-48% -$2.76M
NSP icon
46
Insperity
NSP
$2.03B
$2.57M 0.9%
30,714
-11,502
-27% -$978K
OMCL icon
47
Omnicell
OMCL
$1.88B
$2.56M 0.9%
19,737
-14,201
-42% -$1.82M
ROKU icon
48
Roku
ROKU
$21.6B
$2.56M 0.89%
7,845
-19,764
-72% -$7.75M
SKX
49
DELISTED
Skechers
SKX
$2.53M 0.88%
+60,569
New +$2.29M
MPWR icon
50
Monolithic Power Systems
MPWR
$61.4B
$2.52M 0.88%
7,135
+1,953
+38% +$711K
1
2
3 4 5

Similar funds

AI
AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return
AB
ANB Bank Denver, Colorado $247M AUM 19.59% 1-Year Est. Return
PWS
Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return
BFM
Blacksheep Fund Management Co. Dublin, Ireland $247M AUM 8.75% 1-Year Est. Return
IFPG
Intrepid Financial Planning Group Carmel, Indiana $248M AUM 19.02% 1-Year Est. Return
SCM
Segra Capital Management Palm Beach, Florida $248M AUM 65.61% 1-Year Est. Return
GWS
Greykasell Wealth Strategies Danville, California $248M AUM 22.08% 1-Year Est. Return
MC
Mount Capital London, United Kingdom $248M AUM 4.81% 1-Year Est. Return

Capital Impact Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, Capital Impact Advisors held 143 positions worth $286M, down 30% from $407M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Capital Impact Advisors withdrew a net $144M in Q1 2021, closing 34 positions and reducing 49 holdings. Its most notable exit was Personalis, an estimated $7.88M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 45% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Capital Impact Advisors opened a new position in Omnicom Group worth $8.82M.

  • Capital Impact Advisors's largest Q1 2021 buy was Omnicom Group: 118,943 shares worth $8.82M.
  • Capital Impact Advisors added most to Cellectis in Q1 2021, an estimated $6.83M increase.
  • Capital Impact Advisors's biggest Q1 2021 reduction was Intellia Therapeutics, cutting an estimated $14.5M.
  • Capital Impact Advisors fully exited Personalis in Q1 2021, selling an estimated $7.88M.
  • Capital Impact Advisors's ten largest holdings make up 24% of its $286M portfolio in Q1 2021.
  • Capital Impact Advisors opened 41 new positions and closed 34 in Q1 2021.
  • Capital Impact Advisors's portfolio value fell 30% quarter-over-quarter to $286M.

Based on Capital Impact Advisors's 13F filing for Q1 2021, filed 18 May 2021.